Jump Main Menu. Go directly to the main content

Sección de idiomas


Fin de la sección de idiomas

Access / Registration

Sección de utilidades

Fin de la sección de utilidades



Start of main content

Metabolism, Model Systems and Therapies for ALS

Life and Matter Sciences Session Tuesday, July 2, 2019 9:45 hours Madrid

General information:

Venue: Fundación Ramón Areces. Calle Vitruvio, 5. 28006. Madrid.

Free admission. Necessary previous online registration. Limited capacity. Simultaneous interpretation.

Organized by:

Fundación Ramón Areces

In cooperation with:

Fundación Francisco Luzón


Mónica Povedano. Hospital Universitario de Bellvitge. 

Isidro Ferrer. Hospital Universitario de Bellvitge.


  • Description
  • Programme

The search for efficient therapies for the treatment of the Amyotrophic Lateral Sclerosis (ALS) requires a translational scientific approach, a research using model systems of the disease with a fast and bidirectional communication with the clinic research.

Fundación Ramón Areces and Francisco Luzón Foundation collaborate organizing this workshop with the aim of creating an environment where the researchers working on ALS, could have the opportunity of share information of the new advances in the field among them and with the public interested in attendance to this workshop.

Along the workshop there will be three main topics to be focused on among the multiple ones composing the research on ALS environment. In first place, we will talk about metabolic alterations in ALS patients, the second topic will be the use of model systems as an approach for the research on ALS. Finally, we will talk about the therapeutic approach to this pathology.

In the workshop there will be the participation of prestigious international and national researchers, preceded by the plenary talk by Dr. Talbot from Oxford University.  

Tuesday, July 2

9:15 h.

Attendee check-in

9:45 h.


Raimundo Pérez-Hernández y Torra 
Director Fundación Ramón Areces.

Federico Mayor Zaragoza 
Consejo Científico Fundación Ramón Areces.

María José Arregui 
Vicepresidenta Ejecutiva de la Fundación Francisco Luzón.

Teresa Chavarría 
Directora General de Planificación, Investigación y Formación de la Consejería de Sanidad de la Comunidad de Madrid.

10:15 h.

Principal conference: Modelling amyotrophic lateral sclerosis in the era of precision medicine

Kevin Talbot
Head of the Division of Clinical Neurology. Nuffield Department of Clinical Neurosciences. University of Oxford. United Kingdom. 

11:00 h.

Metabolic alteration in ALS


Francisco Gil Bea
Instituto de Investigación Sanitaria Biodonostia. CIBERNED (ISCIII).


Hélène Blasco
Université de Tours, France.

11:35 h.


12:00 h.

ALs Models


Josep Esquerda
Universitat de Lleida.


Murine models of ALS

Abraham Acevedo Arozena
Unidad de Investigación del Hospital Universitario de Canarias, Fundación Canaria de Investigación Sanitaria (FUNCANIS). CIBERNED (ISCIII).

Human in vitro models to reconstruct pathogenic mechanisms in ALS

María Demestre
Stem Cell Group. University of Ulm. Germany.

13:10 h.

Targeting TDP-43 with protein kinase inhibitors as a new therapeutic strategy for ALS


Ana Cristina Calvo
Universidad de Zaragoza.


Ana Martínez Gil
Centro de Investigaciones Biológicas (CIB-CSIC - CIBERNED (ISCIII) ). Consorcio ELA-Madrid.

13:45 h.

Closing remarks

Alejandro Arranz 
Director General de Investigación e Innovación de la Consejería de Educación e Investigación de la Comunidad de Madrid.

  • Activities related
  • Projects related
  • News related
  • Publications related

see all

End of main content